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pneumoniae,  following  the  introduction  of  the  new 
oxyiminocephalosporins,  including  cefotaxime,  aztreonam 
and  ceftazidime.1    These  enzymes  hydrolyze  oximino-
b-lactams,  including  the  third  generation  cephalosporins, 
thereby  conferring  antibiotic  resistant  in  those  organisms 
which  carry  the  esbl  resistance  determinant  gene 
loci.2    Such  loci  are  carried  in  several  genera  with  the 

















Therefore,  it  was  the  aim  of  this  small  study,  to  employ 
molecular  methods  to  screen  animal,  food  and  water 






Source of E. coli isolates
E. coli isolates (n=317) as detailed in Table 1, were examined ©  The Ulster Medical Society, 2010.










DNA extraction, PCR  amplification & amplicon detection
E. coli isolates (table 1) were subcultured onto Columbia 















as  positive  controls.    In  addition,  the  MA1/MA2  primer 
combination were challenged with seven non-esbl producing 
















pair  was  successful  at  identifying  the  esbl  gene  locus  in 
all  esbl-producing  isolates,  whereas  no  PCR  amplicon 
































varying  antibiograms,  suggesting  multiple  strains.  In  the 

















hospitalized  patients  demonstrated  various  risk  factors 
for  acquisition  of  an  esbl-producing  organism  in  the 
community.    In  the  first  study  by  Colodner  et  al.11,  311 
non-hospitalized  patients  with  community-acquired  UTIs, 
showed that (i) previous hospitalization in the past 3 months, 
(ii). antibiotic treatment in the past 3 months, (iii) age over 
60  years,  (iv)  diabetes,  (v)  male  gender,  (vi)  Klebsiella 
pneumoniae infection, (vii) previous use of third-generation 
cephalosporins,  (viii)  previous  use  of  second-generation 












for  developing  an  esbl-associated  infection,  there  was  no 
discussion in either study, as to where the esbl-producing ©  The Ulster Medical Society, 2010.
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the  presence  of  CTX-M-2  in  E.  coli  from  bovine  faecal 












isolates  can  be  generated  de  novo  and  demonstrated  the 
presence of an AmpC-like esbl in Enterobacteraecaae from 






description (origin, date) and presence of extended spectrum b-lactamase bla CTX-M phylogenetic groups in E. coli 





























































































area  included  agricultural  run-off  and  sewage  treatment 
works.  No CTX-M phylogenetic groups were observed in 
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